URBANI, GINEVRA
 Distribuzione geografica
Continente #
AS - Asia 597
NA - Nord America 495
EU - Europa 333
SA - Sud America 91
AF - Africa 15
OC - Oceania 1
Totale 1.532
Nazione #
US - Stati Uniti d'America 466
SG - Singapore 232
IT - Italia 117
CN - Cina 92
HK - Hong Kong 82
BR - Brasile 65
RU - Federazione Russa 51
BD - Bangladesh 49
KR - Corea 40
VN - Vietnam 38
DE - Germania 32
IE - Irlanda 24
FR - Francia 21
FI - Finlandia 20
CA - Canada 15
IN - India 13
AT - Austria 12
GB - Regno Unito 11
NL - Olanda 10
IQ - Iraq 9
PL - Polonia 9
MX - Messico 8
PK - Pakistan 8
AR - Argentina 7
CO - Colombia 7
SA - Arabia Saudita 7
SE - Svezia 7
ZA - Sudafrica 7
EC - Ecuador 6
TR - Turchia 6
ID - Indonesia 5
UA - Ucraina 5
JP - Giappone 4
BO - Bolivia 3
ES - Italia 3
BZ - Belize 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GP - Guadalupe 2
KW - Kuwait 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
YT - Mayotte 1
Totale 1.532
Città #
Singapore 180
San Jose 84
Hong Kong 82
Ashburn 78
Perugia 44
Seoul 39
Santa Clara 25
Dublin 22
Moscow 22
Munich 22
Beijing 20
Boardman 20
New York 19
Lauterbourg 18
Piscataway 18
Los Angeles 16
Hanoi 14
Chandler 12
Ho Chi Minh City 9
São Paulo 9
Turku 9
Hefei 8
Helsinki 8
Naples 8
The Dalles 8
Warsaw 8
Amsterdam 7
Brooklyn 7
Baghdad 6
Stockholm 6
Vienna 6
Buffalo 5
Council Bluffs 5
Dallas 5
Montreal 5
Querétaro 5
Seattle 5
Vicenza 5
Denver 4
Florence 4
Johannesburg 4
Nuremberg 4
Orem 4
Phoenix 4
Poplar 4
Tokyo 4
Toronto 4
Atlanta 3
Bologna 3
Curitiba 3
Fortaleza 3
Jeddah 3
Lahore 3
Lappeenranta 3
Mexico City 3
Milan 3
New Delhi 3
Rome 3
San Francisco 3
Turin 3
Abidjan 2
As Sālimīyah 2
Bangkok 2
Bogotá 2
Brasília 2
Cape Town 2
Catania 2
Charlotte 2
Chennai 2
Chicago 2
Cochabamba 2
Empoli 2
Frankfurt am Main 2
Guayaquil 2
Houston 2
Irpin 2
Istanbul 2
Karachi 2
Philadelphia 2
Pittsburgh 2
Prato 2
Qingdao 2
Quito 2
Riyadh 2
San José 2
Santa Rosa 2
Sorocaba 2
Vancouver 2
Addis Ababa 1
Ahmedabad 1
Alagoinhas 1
Ambato 1
Ambāla 1
Ankara 1
Anyang 1
Araraquara 1
Araxá 1
Baie-Mahault 1
Barcelona 1
Bari 1
Totale 1.012
Nome #
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 104
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 103
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 85
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 85
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 84
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 82
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 81
Bile acids and bile acid activated receptors in the treatment of Covid-19 80
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 80
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 78
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 76
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 75
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 70
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 68
Immunology of bile acids regulated receptors 66
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 64
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics 58
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 56
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 52
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis 45
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders 33
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma 21
A bile acid–GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis 19
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy 3
Totale 1.568
Categoria #
all - tutte 6.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202384 4 1 0 4 10 12 0 4 46 0 0 3
2023/202493 2 2 2 2 10 2 20 12 19 4 11 7
2024/2025377 6 29 20 25 23 36 17 46 66 21 54 34
2025/20261.008 69 68 59 163 118 62 125 42 103 84 63 52
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 1.568